Trial intelligence / Profile preview

Oral uracil pharmacokinetics in colorectal cancer patients

NL-OMON28016Recruiting

Sponsor
Leiden University Medical Center
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of uracil in colorectal cancer (CRC) and dihydropyrimidine dehydrogenase deficiency (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Uracil AUC comparison. Started Aug 2011; status: recruiting.

02

Drugs

uracil
03

Conditions

colorectal cancer (CRC)dihydropyrimidine dehydrogenase deficiency

Beyond the preview

Go deeper on NL-OMON28016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call